⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for metastatic salivary gland carcinoma

Every month we try and update this database with for metastatic salivary gland carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) for Recurrent, Metastatic, or Unresectable HER2-Positive Salivary Gland CancerNCT05408845
Metastatic Sali...
Recurrent Saliv...
Stage III Major...
Stage IV Major ...
Unresectable Sa...
Docetaxel
Questionnaire A...
Trastuzumab
Trastuzumab Emt...
18 Years - NRG Oncology
Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland CancerNCT04895735
Metastatic Sali...
Recurrent Saliv...
Stage IV Major ...
Adenoid Cystic ...
Pembrolizumab
Pemetrexed Diso...
Biospecimen Col...
Computed Tomogr...
Positron Emissi...
Magnetic Resona...
PSMA PET Scan
18 Years - Mayo Clinic
Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland CancerNCT04895735
Metastatic Sali...
Recurrent Saliv...
Stage IV Major ...
Adenoid Cystic ...
Pembrolizumab
Pemetrexed Diso...
Biospecimen Col...
Computed Tomogr...
Positron Emissi...
Magnetic Resona...
PSMA PET Scan
18 Years - Mayo Clinic
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: